Mid-term syllabus of Biochem-403: Introduction to Biosafety, Laboratory hazards, Biosafety levels of research laboratories, Good laboratory practices, International rules & regulations for Biosafety, GMOs handling, Laboratory acquired infections and their transmission routs, Bio waste disposal,
…. PLUS…. First 150 MCQs from chapters 3 of the book ” MCQs in Biochemistry”. MCQs from the taught concepts and book chapters will also appear in the exam.
Final exam Biochem-403: Introduction to bioethics, GMOs related ethics, Ethical issues related to reproductive & cloning technologies, Role of institutional bioethical committees.
…. PLUS…. First 150 MCQs from chapters 3 of the book ” MCQs in Biochemistry”. MCQs from the taught concepts and book chapters will also appear in the exam.
Start preparing your presentations and assignments….. The presentations will be started right after the mid-term exam.
NO EXCUSE WILL BE ACCEPTED
__________________________________________________________________________________
Objective questions will be from the lectures, manuals, and books uploaded on this web-page.
__________________________________________________________________________________
Assignments and presentations:
- The weightage of the assignment and presentation will be decided later.
- Start preparing your presentations and assignments.
- The presentations will also be started right after the mid-term exam.
- PPT file should not contain any designing/colours other than figures and diagrams.
- Slides should be in 16X9 ratio.
- Fonts of all header should be same and of all other text should be same.
- For detailed guidelines about the presentation of research article, visit: https://www.lifesciencesorg.combiochem-720/
- Download the template ppt file to make your presentation. The link is here (copy this link and paste in a new tab).
- Strictly follow the ppt format and it is better if you write and paste your material in the same ppt file.
K. General Question to be asked during the presentation
- 1) Pathway or importance of gene/technology/discovery
- 2) Rationale
- 3) Conclusion of the full article
- 4) Conclusion of every figure
- 5) New findings presented in the article
- 6) Applications of the findings
- 7) Future prospective
- 8) Applications of the work
- 9) Principle of every technique used in the research article
Moreover, provide me a printed summary of your article containing the above headings given under ‘K’.
L. During Presentations, for EVERY FIGURE and graph, we may ask:
1. The Principle of the experiment.
2. The Reason for doing the experiment/s.
3. The Physiological importance of the figure.
4. The Conclusions of the figure
5. Prepare well objectively and subjectively
______________________________________________________________________________
Microsoft teams will be used whenever online classes will be held. You must make your first name as your registration number.
2017-ag-9382 Haidar Iftikhar
2017-ag-10077 Ahmad Faraz
______________________________________________________________________________
Microsoft Teams link for classes is given below:
https://teams.microsoft.com/l/meetup-join/19:[email protected]/1662975049970?context=%7B%22Tid%22:%2275df096c-8b72-48e4-9b91-cbf79d87ee3a%22,%22Oid%22:%22c066ef7d-a967-4f2e-b3ad-08e007c9866c%22%7D
BIOCHEM-403 BIOSAFETY AND ETHICS 3(3-0)
Objectives
- Introduce the biosafety regulations and ethical concepts in research
- Emphasize on intellectual property rights issues and need for knowledge in patents.
- Apply the concepts of biosafety and better communicate risk management to the public
Theory
Introduction to Biosafety, Laboratory hazards, Biosafety levels of research laboratories, Good laboratory practices, International rules & regulations for Biosafety, GMOs handling, Laboratory acquired infections and their transmission routs, Bio waste disposal, Introduction to bioethics, GMOs related ethics, Ethical issues related to reproductive & cloning technologies, Role of institutional bioethical committees.
Suggested Readings
- Dawn P. Wooley, Karen B. Byers. Biological Safety: Principles and Practices, 5th Edition.2017. ASM Press.
- Department of Health and Human Services. Biosafety in Microbiological and Biomedical Laboratories. 5th Edition.2016. LULU Press.
- Goel and Parashar. IPR Biosafety and Bioethics. Kindle Edition.2013. Pearson Education.
- Bioethics & Biosafety in Biotechnology by V Sree Krishna. 2011.New Age International Limited Publishers
- Laboratory Biosafety manual 3rd edition. WHO. 2006. AITBS publishers and distributors, India.
Biochem-403, BS Biochem, 3rd, M-Winter 2023, Dr. Muhammad Ali; 28-08-2023 | ||||
Sr. | Ag No. | Student’s Name | Group | Research article for presentation and 1 page summary |
1 | 2022-ag-5240 | TAFSEELA AMJAD | G1 | A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors |
2 | 2022-ag-5241 | ALISHA | ||
3 | 2022-ag-5242 | ANSA BIBI | ||
4 | 2022-ag-5243 | HADIA UMAR | ||
5 | 2022-ag-5244 | MARYAM KHALIL | ||
6 | 2022-ag-5245 | AHMAD HASSAN TARIQ | ||
7 | 2022-ag-5246 | ESHA ARSHAD | ||
8 | 2022-ag-5247 | Asma Nasir | ||
9 | 2022-ag-5248 | FARIA NAWAZ | ||
10 | 2022-ag-5249 | ESHA TAHIR | ||
11 | 2022-ag-5251 | SHAFA SAJJAD | G2 | Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy |
12 | 2022-ag-5252 | QIRAT RAZZAQ | ||
13 | 2022-ag-5253 | KASHAF ALAM | ||
14 | 2022-ag-5254 | AISHA ALI | ||
15 | 2022-ag-5255 | ZAINAB | ||
16 | 2022-ag-5256 | BUSHRA NOOR | ||
17 | 2022-ag-5257 | MARIYAM | ||
18 | 2022-ag-5258 | IQRA BATOOL | ||
19 | 2022-ag-5259 | MANAHIL YOUNIS | ||
20 | 2022-ag-5260 | KHUZAIMA NADEEM | G3 | A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors |
21 | 2022-ag-5261 | AYESHA NAVEED | ||
22 | 2022-ag-5262 | FIZA FATIMA | ||
23 | 2022-ag-5263 | VANEEZA AHMAD | ||
24 | 2022-ag-5264 | HAFSA TAHIRA | ||
25 | 2022-ag-5265 | MUHAMMAD MUZAMMAL IKRAM | ||
26 | 2022-ag-5266 | MUHAMMAD BILAL | ||
27 | 2022-ag-5267 | ABDUL HANNAN | ||
28 | 2022-ag-5268 | FAIZA LARAIB | G5 | Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1 |
29 | 2022-ag-5269 | SAHER FARAZ | ||
30 | 2022-ag-5270 | MUHAMMAD USMAN | ||
31 | 2022-ag-5271 | MANAHIL MALIK | ||
32 | 2022-ag-5272 | MAHEEN ASIF CHAUDHARY | ||
33 | 2022-ag-5273 | ZAINAB | ||
34 | 2022-ag-5274 | MUNIM ALI | ||
35 | 2022-ag-5276 | MUBASHAR ALI | ||
36 | 2022-ag-5277 | MUHAMMAD SHAHBAZ JAMIL | G5 | Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer |
37 | 2022-ag-5278 | KISA FATIMA | ||
38 | 2022-ag-5279 | MUHAMMAD MOHSIN RAZA | ||
39 | 2022-ag-5280 | KASHAF FATIMA | ||
40 | 2022-ag-5281 | LAIBA AZHAR | ||
41 | 2022-ag-5282 | ANEELA SHAHZADI | ||
42 | 2022-ag-5283 | RABIA RAMZAN | ||
43 | 2022-ag-5284 | EMAN FATIMA | ||
44 | 2022-ag-5285 | MARYAM SADDIQUA | G6 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity |
45 | 2022-ag-5286 | ARIBA AKBAR | ||
46 | 2022-ag-5287 | MARWA NADEEM | ||
47 | 2022-ag-5288 | GHULAM HUSSAIN | ||
48 | 2022-ag-5289 | SAMANIA KHALID | ||
49 | 2022-ag-5292 | LUBABA SAEED | ||
50 | 2022-ag-5293 | NIMRA EMAN | ||
51 | 2022-ag-5294 | RIZA SIKANDAR | ||
52 | 2022-ag-5295 | HAMNA IRSHAD | G7 | BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells |
53 | 2022-ag-5296 | MARYAM HAMDA | ||
54 | 2022-ag-5297 | MARYAM RANI | ||
55 | 2022-ag-5298 | ALI | ||
56 | 2022-ag-5299 | HAIQA AKHTAR | ||
57 | 2022-ag-5300 | SANAA ABBAS | ||
58 | 2022-ag-5301 | ABDUL REHMAN | ||
59 | 2022-ag-5302 | AIMAN HAMID | ||
60 | 2022-ag-5303 | MARIAM FATIMA | ||
61 | 2022-ag-5304 | MALAIKA NADEEM | G8 | The topoisomerase inhibitor CPT-11 prevents the growth and metastasis of lung cancer cells in nude mice by inhibiting EGFR/ MAPK signaling pathway |
62 | 2022-ag-5305 | MAMOONA | ||
63 | 2022-ag-5306 | SABA JAVED | ||
64 | 2022-ag-5307 | MARRIAM SALEEM | ||
65 | 2022-ag-5308 | AFSHEEN QADRI | ||
66 | 2022-ag-5309 | ITRAT FATIMA | ||
67 | 2022-ag-5311 | MAHA | ||
68 | 2022-ag-5312 | ZEESHAN ALI SHAHZAD | ||
69 | 2022-ag-5313 | FARWA ASGHAR | ||
70 | 2022-ag-5314 | UMER AKMAL | G9 | Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model |
71 | 2022-ag-5315 | TAYYABA EMAN | ||
72 | 2022-ag-5316 | DANIYA PAKEEZA | ||
73 | 2022-ag-5317 | TAYBA ALI HUSSAIN | ||
74 | 2022-ag-5318 | AIMAN SHABBIR | ||
75 | 2022-ag-5319 | TAYYABA NAVEED | ||
76 | 2021-ag-7031 | AYESHA ASLAM | ||
77 | 2022-ag-5320 | Fatima Idrees | ||
78 | 2022-ag-5337 | ZAINAB | G10 | ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression |
79 | 2022-ag-5338 | Aliza Ahmad | ||
81 | 2022-ag-5340 | Noor Bhari | ||
82 | 2022-ag-5354 | Hira Fatima | ||
83 | 2022-ag-5355 | Ifra Muzaffar | ||
84 | 2022-ag-5361 | Tayyavba shaukat | ||
85 | 2022-ag-5364 | Fatima Miraj | ||
86 | 2022-ag-5365 | Sabahat Masood |
Biosafety Manual
https://www.unr.edu/ehs/policies-manuals/biosafety-manual
- Purpose, Scope, and Responsibilities
- Approval of Research Projects
- Biosafety Regulations and Guidelines
- Biosafety Principles
- Laboratory Biosafety Practices
- Laboratory Training
- Decontamination
- Laboratory Ventilation for Biosafety
- Human Tissue and Cell Culture
- Work with Biological Toxins
- Incident Response
- Incident Reporting
- Biohazardous Waste
- CDC/USDA Select Agents
- Animal Care and Use in University Research, Testing, and Education Programs
- Packaging and Shipping Infectious Agents
Comments are closed.